WO2003075939A1 - Substance contenant de la saponine de soja et procede de production associe - Google Patents
Substance contenant de la saponine de soja et procede de production associe Download PDFInfo
- Publication number
- WO2003075939A1 WO2003075939A1 PCT/JP2003/002881 JP0302881W WO03075939A1 WO 2003075939 A1 WO2003075939 A1 WO 2003075939A1 JP 0302881 W JP0302881 W JP 0302881W WO 03075939 A1 WO03075939 A1 WO 03075939A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- saponin
- soybean
- isoflavone
- producing
- organic solvent
- Prior art date
Links
- 229930182490 saponin Natural products 0.000 title claims abstract description 150
- 150000007949 saponins Chemical class 0.000 title claims abstract description 150
- 239000001397 quillaja saponaria molina bark Substances 0.000 title claims abstract description 141
- 235000010469 Glycine max Nutrition 0.000 title claims abstract description 88
- 244000068988 Glycine max Species 0.000 title claims abstract description 86
- 239000000463 material Substances 0.000 title claims description 34
- 238000000034 method Methods 0.000 title claims description 21
- 230000008569 process Effects 0.000 title description 2
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 claims abstract description 63
- 235000008696 isoflavones Nutrition 0.000 claims abstract description 63
- 238000000605 extraction Methods 0.000 claims abstract description 47
- -1 malonyl isoflavone glycoside Chemical compound 0.000 claims abstract description 44
- GOMNOOKGLZYEJT-UHFFFAOYSA-N isoflavone Chemical compound C=1OC2=CC=CC=C2C(=O)C=1C1=CC=CC=C1 GOMNOOKGLZYEJT-UHFFFAOYSA-N 0.000 claims abstract description 33
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 53
- 239000000284 extract Substances 0.000 claims description 47
- 239000003495 polar organic solvent Substances 0.000 claims description 36
- 238000004519 manufacturing process Methods 0.000 claims description 25
- 239000000126 substance Substances 0.000 claims description 25
- 239000002994 raw material Substances 0.000 claims description 15
- 239000003463 adsorbent Substances 0.000 claims description 12
- 239000002798 polar solvent Substances 0.000 claims description 5
- 235000003687 soy isoflavones Nutrition 0.000 claims description 4
- 229930182470 glycoside Natural products 0.000 abstract description 28
- 150000002515 isoflavone derivatives Chemical class 0.000 abstract description 18
- ZWSNUPOSLDAWJS-QNDFHXLGSA-N 6,7-dihydroxy-3-[4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]chromen-4-one Chemical compound OC[C@H]1O[C@@H](Oc2ccc(cc2)-c2coc3cc(O)c(O)cc3c2=O)[C@H](O)[C@@H](O)[C@@H]1O ZWSNUPOSLDAWJS-QNDFHXLGSA-N 0.000 abstract description 9
- NIHOFXGDOZCCKN-UHFFFAOYSA-N 2-acetyl-3-phenylchromen-4-one Chemical compound CC(=O)C=1OC2=CC=CC=C2C(=O)C=1C1=CC=CC=C1 NIHOFXGDOZCCKN-UHFFFAOYSA-N 0.000 abstract description 6
- DKVBOUDTNWVDEP-NJCHZNEYSA-N teicoplanin aglycone Chemical compound N([C@H](C(N[C@@H](C1=CC(O)=CC(O)=C1C=1C(O)=CC=C2C=1)C(O)=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)OC=1C=C3C=C(C=1O)OC1=CC=C(C=C1Cl)C[C@H](C(=O)N1)NC([C@H](N)C=4C=C(O5)C(O)=CC=4)=O)C(=O)[C@@H]2NC(=O)[C@@H]3NC(=O)[C@@H]1C1=CC5=CC(O)=C1 DKVBOUDTNWVDEP-NJCHZNEYSA-N 0.000 abstract 1
- 235000017709 saponins Nutrition 0.000 description 136
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 23
- 230000007423 decrease Effects 0.000 description 15
- TWCMVXMQHSVIOJ-UHFFFAOYSA-N Aglycone of yadanzioside D Natural products COC(=O)C12OCC34C(CC5C(=CC(O)C(O)C5(C)C3C(O)C1O)C)OC(=O)C(OC(=O)C)C24 TWCMVXMQHSVIOJ-UHFFFAOYSA-N 0.000 description 12
- PLMKQQMDOMTZGG-UHFFFAOYSA-N Astrantiagenin E-methylester Natural products CC12CCC(O)C(C)(CO)C1CCC1(C)C2CC=C2C3CC(C)(C)CCC3(C(=O)OC)CCC21C PLMKQQMDOMTZGG-UHFFFAOYSA-N 0.000 description 12
- PFOARMALXZGCHY-UHFFFAOYSA-N homoegonol Natural products C1=C(OC)C(OC)=CC=C1C1=CC2=CC(CCCO)=CC(OC)=C2O1 PFOARMALXZGCHY-UHFFFAOYSA-N 0.000 description 12
- 229920005989 resin Polymers 0.000 description 12
- 239000011347 resin Substances 0.000 description 12
- 238000000746 purification Methods 0.000 description 11
- OZBAVEKZGSOMOJ-MIUGBVLSSA-N glycitin Chemical compound COC1=CC(C(C(C=2C=CC(O)=CC=2)=CO2)=O)=C2C=C1O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O OZBAVEKZGSOMOJ-MIUGBVLSSA-N 0.000 description 10
- ZQSIJRDFPHDXIC-UHFFFAOYSA-N daidzein Chemical compound C1=CC(O)=CC=C1C1=COC2=CC(O)=CC=C2C1=O ZQSIJRDFPHDXIC-UHFFFAOYSA-N 0.000 description 9
- 230000000694 effects Effects 0.000 description 9
- 238000011084 recovery Methods 0.000 description 8
- 239000002904 solvent Substances 0.000 description 8
- 230000000052 comparative effect Effects 0.000 description 7
- 238000000926 separation method Methods 0.000 description 7
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 238000010828 elution Methods 0.000 description 6
- 150000002338 glycosides Chemical class 0.000 description 6
- XJTZHGNBKZYODI-UHFFFAOYSA-N Glycitin Natural products OCC1OC(Oc2ccc3OC=C(C(=O)c3c2CO)c4ccc(O)cc4)C(O)C(O)C1O XJTZHGNBKZYODI-UHFFFAOYSA-N 0.000 description 5
- 235000013305 food Nutrition 0.000 description 5
- ZCOLJUOHXJRHDI-CMWLGVBASA-N genistein 7-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 ZCOLJUOHXJRHDI-CMWLGVBASA-N 0.000 description 5
- 238000001179 sorption measurement Methods 0.000 description 5
- 238000004809 thin layer chromatography Methods 0.000 description 5
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- GMTUGPYJRUMVTC-UHFFFAOYSA-N Daidzin Natural products OC(COc1ccc2C(=O)C(=COc2c1)c3ccc(O)cc3)C(O)C(O)C(O)C=O GMTUGPYJRUMVTC-UHFFFAOYSA-N 0.000 description 3
- KYQZWONCHDNPDP-UHFFFAOYSA-N Daidzoside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 KYQZWONCHDNPDP-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 230000003078 antioxidant effect Effects 0.000 description 3
- 235000007240 daidzein Nutrition 0.000 description 3
- KYQZWONCHDNPDP-QNDFHXLGSA-N daidzein 7-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 KYQZWONCHDNPDP-QNDFHXLGSA-N 0.000 description 3
- 238000005194 fractionation Methods 0.000 description 3
- 238000002523 gelfiltration Methods 0.000 description 3
- 235000006539 genistein Nutrition 0.000 description 3
- TZBJGXHYKVUXJN-UHFFFAOYSA-N genistein Natural products C1=CC(O)=CC=C1C1=COC2=CC(O)=CC(O)=C2C1=O TZBJGXHYKVUXJN-UHFFFAOYSA-N 0.000 description 3
- 229940045109 genistein Drugs 0.000 description 3
- 125000000346 malonyl group Chemical group C(CC(=O)*)(=O)* 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- CHRJZRDFSQHIFI-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;styrene Chemical compound C=CC1=CC=CC=C1.C=CC1=CC=CC=C1C=C CHRJZRDFSQHIFI-UHFFFAOYSA-N 0.000 description 2
- FRAUJUKWSKMNJY-UHFFFAOYSA-N 5-hydroxy-3-(4-hydroxyphenyl)-7-(6-malonyl-beta-D-glucopyranosyloxy)-4H-1-benzopyran-4-one Natural products OC1C(O)C(O)C(COC(=O)CC(O)=O)OC1OC1=CC(O)=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 FRAUJUKWSKMNJY-UHFFFAOYSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- ZCOLJUOHXJRHDI-FZHKGVQDSA-N Genistein 7-O-glucoside Natural products O([C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O1)c1cc(O)c2C(=O)C(c3ccc(O)cc3)=COc2c1 ZCOLJUOHXJRHDI-FZHKGVQDSA-N 0.000 description 2
- CJPNHKPXZYYCME-UHFFFAOYSA-N Genistin Natural products OCC1OC(Oc2ccc(O)c3OC(=CC(=O)c23)c4ccc(O)cc4)C(O)C(O)C1O CJPNHKPXZYYCME-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- YCUNGEJJOMKCGZ-UHFFFAOYSA-N Pallidiflorin Natural products C1=CC(OC)=CC=C1C1=COC2=CC=CC(O)=C2C1=O YCUNGEJJOMKCGZ-UHFFFAOYSA-N 0.000 description 2
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 2
- DXWGBJJLEDQBKS-UHFFFAOYSA-N acetylgenistin Natural products OC1C(O)C(O)C(COC(=O)C)OC1OC1=CC(O)=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 DXWGBJJLEDQBKS-UHFFFAOYSA-N 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000003579 anti-obesity Effects 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- FRAUJUKWSKMNJY-RSEYPYQYSA-N malonylgenistin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](COC(=O)CC(O)=O)O[C@H]1OC1=CC(O)=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 FRAUJUKWSKMNJY-RSEYPYQYSA-N 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 238000011403 purification operation Methods 0.000 description 2
- 238000011002 quantification Methods 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000012085 test solution Substances 0.000 description 2
- 206010067125 Liver injury Diseases 0.000 description 1
- 108010073771 Soybean Proteins Proteins 0.000 description 1
- 101710162629 Trypsin inhibitor Proteins 0.000 description 1
- 229940122618 Trypsin inhibitor Drugs 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 235000013527 bean curd Nutrition 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 229920001429 chelating resin Polymers 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000006114 decarboxylation reaction Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 231100000753 hepatic injury Toxicity 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000005934 immune activation Effects 0.000 description 1
- 230000000415 inactivating effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- OWMHCYFEIJPHFB-UHFFFAOYSA-N malonyl glycitin Natural products COc1cc2c(cc1OC1OC(COC(=O)CC(O)=O)C(O)C(O)C1O)occ(-c1ccc(O)cc1)c2=O OWMHCYFEIJPHFB-UHFFFAOYSA-N 0.000 description 1
- OWMHCYFEIJPHFB-GOZZSVHWSA-N malonylglycitin Chemical compound COC1=CC(C(C(C=2C=CC(O)=CC=2)=CO2)=O)=C2C=C1O[C@@H]1O[C@H](COC(=O)CC(O)=O)[C@@H](O)[C@H](O)[C@H]1O OWMHCYFEIJPHFB-GOZZSVHWSA-N 0.000 description 1
- 125000000896 monocarboxylic acid group Chemical group 0.000 description 1
- 150000002772 monosaccharides Chemical group 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 238000004810 partition chromatography Methods 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 230000006920 protein precipitation Effects 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 238000012113 quantitative test Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 235000019710 soybean protein Nutrition 0.000 description 1
- 229930188627 soysaponin Natural products 0.000 description 1
- 239000012086 standard solution Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 239000002753 trypsin inhibitor Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Definitions
- the present invention relates to a soybean saponin-containing substance and a method for producing the same.
- Soybean saponin (hereinafter simply referred to as “saponin”) is a generic term for saponins contained in soybean materials, and is contained in soybean hypocotyls at about 2 to 4% by weight.
- Sosabogenol A is an aglycone skeleton
- Darsap A saponin a bisdesmosidic saponin in which a sugar chain is ether-linked to C13 and C-22 positions of aglycone
- Sosasapogenol B It is classified as a group B saponin, which is a monodesmoside saponin with an aglycone skeleton and a monosaccharide chain with an ether-linked sugar chain at the C-3 position of the aglycone.
- saponins in which the sugar chain is acetylated have been reported (Kitagawa et al., Chem. Phrm. Bull, 33, (1985)).
- the soybean material contains isoflavone as a trace component other than savonone, and the soybean hypocotyl contains about 1 to 2% by weight.
- Isoflavones have daidzein, glycitin, or genistein as the aglycone skeleton, and the isoflavone aglycone, isoflavone glycoside having a sugar chain bonded at the 6-position, and furthermore, the sugar chain has an acetyl group (--COCH 3 ), a malonyl group Acetyl isofura having (-COCH 2 COOH) as a functional group Bon glycoside and malonyl isoflavone glycoside.
- saponin has various physiological activities such as anti-obesity effect, antioxidant effect and immune activation effect. If there is a material containing saponin in high concentration, it can be easily added to various foods and drinks. It is possible to use it.
- an object of the present invention is to easily separate saponin and isoflavones extracted from soybean raw materials, and to industrially obtain a saponin-containing substance with high purity and high yield. Disclosure of the invention
- the present inventors have studied the extraction conditions for the above problems in order to increase the purity and yield of saponin. That is, the extraction temperature was raised to a high temperature or the pH was changed. However, under high temperature conditions, the yield of saponin increased, but at the same time, solids other than saponin were also extracted, resulting in a decrease in the purity of saponin. Therefore, under these conditions, a complicated two-stage purification operation as in the prior art is required, which eventually causes a decrease in the yield. Therefore, another method was determined.
- saponin is similar in hydrophobicity to isoflavone glycosides, acetyl isoflavone glycosides, and isoflavone aglycone, among isoflavones, it should be difficult to separate them by a technique utilizing these properties.
- malonyl isoflavone glycosides have a relatively high polarity due to having a dissociating group, and are easily separated from saponin by an adsorbent.
- Malonyl isoflavone glycosides are naturally contained in soybean most in the natural state, but are heat-labile compounds, and are easily heated to produce isoflavone glycosides, acetyl isoflavone glycosides, or isoflavone ⁇ -glycans. It has the property of changing into glycones. Based on the above findings, in order to obtain saponin with high purity and high yield, malonyl isoflavone glycoside in soybean material should not be changed to isoflavone glycoside, acetyl isoflavone glycoside or isoflavone aglycone.
- a method for producing a soybean saponin-containing material comprising preparing a water-containing polar organic solvent extract satisfying the following conditions a) and b) from soybean raw materials:
- the content of malonyl isoflavone glycoside in the total isoflavone content of the extract is not less than 25% by weight
- soybean saponin-containing material is 60% by weight or more, 2.
- a method for producing a soybean saponin-containing substance characterized by purifying an aqueous polar organic solvent extract prepared by the method according to any one of the above 1 to 5 by an adsorbent treatment. After treating the aqueous polar organic solvent extract prepared by the method according to any one of the above with an adsorbent, the soy isoflavone-containing fraction is eluted with a water-containing polar solvent having a water content of 65 to 90% by volume, and then eluted.
- a method for producing a soybean saponin-containing substance comprising eluting a soybean saponin-containing fraction with a water-containing polar solvent having a water content of 5 to 40% by volume,
- the present invention relates to a process for preparing an extract containing saponin from a soybean material using a water-containing polar organic solvent (hereinafter referred to as “water-containing polar organic solvent extract”). And the saponin extraction into a water-containing polar organic solvent is carried out such that the content of malonyl isoflavone glycoside in the above is 25% by weight or more, preferably 40% by weight or more, more preferably 50% by weight or more. It is characterized in that the extraction is performed so that the ratio is 60% by weight or more, preferably 70% by weight or more, and more preferably 80% by weight or more. By performing extraction under such conditions, it becomes possible to industrially obtain saponin with high purity and high yield.
- water-containing polar organic solvent extract a water-containing polar organic solvent
- an aqueous polar organic solvent extract so as to satisfy this condition, Appropriately combine the production conditions such as soy raw material, type of water-containing polar organic solvent and water content, extraction temperature, pH during extraction, and extraction method. Preferred embodiments for obtaining an aqueous polar organic solvent extract satisfying the above conditions will be described below.
- a soybean raw material containing saponin such as whole soybean, dehulled soybean, dehulled dehypocotyl soybean, defatted soybean, soybean hypocotyl may be used.
- the amount is relatively high, also antioxidant effect among the saponin is said to particularly strong (Daiminami et al, Proc.Symp.WAKAN-yAKU, I 4, 15 7 -1 62 (19 8 1).) group a
- soybean hypocotyls with high saponin content about 2 to 4% by weight
- processed soybean products such as isolated soybean protein, okara, and tofu can be used. is there. Soybean hypocotyls that have a low contamination of seed coat and high hypocotyl purity are preferred.
- the soybean hypocotyl may be subjected to pretreatment such as dry heat heating or wet heat heating for the purpose of improving flavor and inactivating trypsin inhibitor, but the malonyl isoflavone glycoside is replaced with isoflavone glycoside or ⁇ -flavonoid. If the treatment is carried out to such an extent that the cetyl isoflavone glycoside is changed, the separation efficiency in the purification step after the extraction may be affected. Therefore, it is preferable to use raw soybean hypocotyls. In the case of pretreatment, it is preferable to keep mild treatment with little change in malonyl isoflavone glycoside.
- Table 1 shows examples of the composition of isoflavones in raw soybean hypocotyls and dry-heated soybean hypocotyls.
- the soybean hypocotyl that was subjected to dry heat heating (roasting) was almost completely malonyl isoflavone glycoside changed to isoflavone glycoside or acetyl isoflavone glycoside. Is not preferred. (table 1 )
- a water-containing polar organic solvent that is, an organic solvent miscible with water and containing a desired proportion of water
- the hydrophilic organic solvent include lower alcohols such as methanol, ethanol and propanol, and acetone. Particularly, it is preferable to use ethanol.
- Non-polar organic solvents such as ether, chloroform and hexane should be avoided because of poor extraction efficiency of glycoside components such as isoflavones and saponins.
- the water content of the water-containing polar organic solvent depends on the type of the polar organic solvent, but may be a ratio that enables high-purity and high-yield extraction of saponin, and is preferably 20 to 85% by volume. More preferably, the reaction can be performed at 25 to 70% by volume, and further preferably 25 to 60% by volume. If the water content is too low, the saponin extraction rate will decrease extremely. If it is too high, the isoflavone glycoside and its malonyl and acetyl derivatives will be decomposed, possibly due to the action of ⁇ -darcosidase present in the soybean hypocotyl, and the isoflavone aglycone ratio will increase.
- the amount of the water-containing polar organic solvent used per one time with respect to the soybean material is not particularly limited, and it depends on the type of the solvent. However, considering the cost, it is preferably 3 to 10 L per kg of the raw material.
- the temperature at which saponin is extracted from soybean raw materials is lower than the temperature at which malonyl isoflavone glycosides are not easily converted to isoflavone glycosides or acetyl isoflavone glycosides, and 10 to 72 ° C. Is more preferable, and 20 to 65 is still more preferable. If the extraction temperature is too low, it is difficult to extract saponin, and the yield tends to decrease. If the extraction temperature is too high, the malonyl group of the malonyl isoflavone glycoside undergoes hydrolysis or decarboxylation, resulting in an increase in isoflavone glycosides and acetyl isoflavone glycosides. And the purity of saponin tends to decrease.
- the pH value of the water-containing polar organic solvent is preferably pH 4 to 9, and more preferably pH 5 to 8. If the pH is too low, depending on the water content of the water-containing polar organic solvent, the saponin in the extract is likely to precipitate as precipitates, and the subsequent fractionation process is troublesome. If the pH is too high, malonylisoflavone glycoside is used. However, it is easily converted to isoflavone glycosides, and the efficiency of separation from saponins tends to decrease.
- the extraction method select a method that can extract the saponin from the soybean raw material into the aqueous polar organic solvent extract at a rate of 60% by weight or more, more preferably 70% by weight or more, and even more preferably 80% by weight or more. do it.
- the method exemplified above may be selected in consideration of the location and cost at the manufacturing site. On the other hand, when the number of extractions is only one, the extraction rate of savones from soybean materials is difficult to increase, and the yield tends to decrease.
- aqueous polar organic solvent extract obtained by the above-described embodiment saponin is recovered in high yield (60% by weight or more) from soybean raw materials, and malonyl isoflavone glycoside in total isoflavones is obtained. Is high (25% by weight or more). Extracts satisfying these conditions make it extremely easy to separate and purify saponin and isoflavones thereafter. On the other hand, extraction under mild conditions was not performed, and the content of malonyl isoflavone glycoside in the total amount of isoflavones in the obtained aqueous polar organic solvent extract was less than 25% by weight.
- acetyl isoflavone glycosides and isoflavone aglycone When the content of saccharides, acetyl isoflavone glycosides and isoflavone aglycone is increased to 75% by weight or more, it becomes difficult to separate from the saponin-containing fraction, resulting in a significant decrease in saponin purity. A purification step will be required.
- the isoflavone fraction can be very easily removed from the obtained aqueous polar organic solvent extract by a commonly used purification means, and a high-purity saponin fraction can be obtained in a high yield.
- the preferred embodiment of the purification step is described below.
- the obtained aqueous polar solvent extract is first treated with an adsorbent. That is, savonine is adsorbed on an adsorbent resin or the like.
- adsorption resin for example, HP-20 (manufactured by Mitsubishi Chemical Corporation) and SP-825 (manufactured by Mitsubishi Chemical Corporation), which are porous styrene / divinylbenzene type resins, can be used.
- Amberlite XAD-2, XAD-4 manufactured by Rohm & Haas Co., Ltd.
- Duolight S-861, S-862 manufactured by Sumitomo Chemical Co., Ltd.
- This operation may be performed in a batch manner by charging the resin into a tank, or may be performed by filling the resin into a force ram.
- the saponin-containing fraction is purified from the liquid. Specifically, it can be purified by the following method.
- Components other than saponin are selectively removed from the fraction adsorbed on the resin with a water-containing polar organic solvent having a high water content.
- the water content of the water-containing polar organic solvent is preferably from 65 to 90% by volume. If the water content is too high, a large amount of solvent is required to elute the isoflavone fraction. On the other hand, if the water content is too low, saponin is eluted at the same time as the isoflavone, so that the separation efficiency is reduced and the saponin purity tends to be reduced. (Eluent of fraction containing saponin)
- a saponin-containing fraction is selectively eluted with a water-containing polar organic solvent having a low water content, and collected.
- the water content of the water-containing polar organic solvent is preferably 5 to 40% by volume, more preferably 10 to 35% by volume. If the water content is too high, not only will a large amount of solvent be required to elute the saponin-containing fraction, but also it will not be possible to completely recover savonin, causing a decrease in yield. On the other hand, if the water content is too low, the elution efficiency decreases and the cost increases. (Processing of saponin-containing fraction)
- the eluate of the saponin-containing fraction thus obtained can be processed into a concentrated solution as it is, or can be processed into a powdery / granular form to obtain a “soy saponin-containing substance”.
- the obtained soybean saponin-containing material has a high purity of a saponin content of 40% by weight or more, preferably 50% by weight per solid content, a high yield from soybean raw materials, and an extremely high production efficiency. It was obtained by
- the obtained saponin-containing fraction contains 60% or more of group A saponin, which is extremely useful as a saponin-containing substance having higher antioxidant properties. is there.
- soybean saponin-containing substance By ingesting the obtained soybean saponin-containing substance, anti-obesity effect, anti-oxidation effect, liver injury improvement effect, serum lipid improvement effect, etc. can be expected, and tablets, confectionery, beverages, other health foods and drinks, pharmaceuticals, and cosmetics. And so on.
- the determination of saponin was performed by thin-layer chromatography.
- the determination of isoflavone was conducted in accordance with the standard analysis method for soybean isoflavone food standard of the Japan Health and Nutrition Food Association. The following describes each method.
- the sample was accurately weighed, methanol was added thereto, and the mixture was stirred and extracted for 1 hour, and then centrifuged to obtain an extract. This was repeated again, and the obtained extract was made up to a constant volume.
- TLC thin layer chromatography
- the saponin spot was confirmed by comparing the Rf value with the saponin sample. Using a standard straight line prepared in advance with a saponin sample, the area integral of the spot was determined, and the amount of saponin was calculated. Table 2 shows the conditions for thin layer chromatography.
- a sample corresponding to 10 mg of soy isoflavone was accurately weighed, and 25 mL of 70% by volume ethanol was added thereto. After extraction with stirring at room temperature for 30 minutes, centrifugation was performed to obtain an extract. The residue was subjected to the same extraction operation twice more. The extract solution for a total of three times was made up to 100 mL with 70% by volume of ethanol, and filtered with a 0.45 mPVDF filter to obtain a test solution.
- the confirmation test for soy isoflavone was 12 kinds of standard products, namely daidzin, genistin, glycitin, daidzein, genistein, glycitin, malonilidine, malonylgenistin, malonyldaricitin, acetildidine, acetylgenistin, acetildaricin (Wako Pure Chemical)
- the same retention time peak was confirmed using Kogyo Co., Ltd.
- 12 isoflavone concentrations (daidine equivalent) were quantified using daidzin standard products, and the true isoflavone concentration was calculated by multiplying by the following quantification coefficient. Concentration was calculated.
- Quantification coefficient of isoflavones daidzin (1,000), genistin (0.814), glycitin (1.090), malonyldidine (1.444), malonylgenistin (1.095), malonylglycitin (1.351), acetildidine (1.094), acetylgenistin (1.064), acetyldaricin (1.197), daidzein (0.583), genistein (0.528), glycitin (0.5740) and various isoflavone concentrations was obtained from the sum of the above.
- the HPLC conditions for the test solution and the standard solution were as shown in Table 3.
- the extract thus obtained was dissolved in water, and SV2 was applied to a column (100 mL) packed with a porous styrene / divinylbenzene type synthetic adsorption resin DIAION HP-20 (manufactured by Mitsubishi Chemical Corporation). Loaded.
- a saponin-containing substance was obtained in the same manner as in Example 1 except that only the number of extractions was one. (Comparative Example 2)
- Example 1 the saponin yield of the extract was as high as 85%, and the abundance ratio of malonyl isoflavone glycoside was as high as 54.2%. As a result, the obtained saponin-containing material had an extremely high saponin content (60%) and a high yield (72%). Isoflavone, which should normally be difficult to separate from saponin, contained only about 2% by weight, indicating that isoflavone and savonin from the extract were very appropriately separated. Furthermore, of the saponins contained in the saponin-containing substance of Example 1, 67% were group A saponins.
- Example 2 as in Example 1, the saponin yield of the saponin-containing material was extremely high (73% by weight), but the ratio of malonyl isoflavone glycoside in the extract was 25.3%. Results The saponin content in the saponin-containing material was lower than in Example 1. However, the saponin content was still 40% by weight, which was a satisfactory content. The reason for the decrease was that the extraction temperature was set to 70 ° C, and the abundance ratio of malonyl isoflavone glycoside in the extract was 25.3%, which was lower than that in Example 1, and conversely acetyl isoflavone This is probably because the abundance ratio of glycosides and isoflavone glycosides increased.
- the saponin yield of the saponin-containing material was reduced to 32% by weight, and the production efficiency was low.
- the water content of the extraction solvent was changed as shown in Table 5 using the same method as in Example 1, and the saponin and isoflavone in the extract were changed. was examined as to how the content changes.
- the water content of the aqueous polar organic solvent extract used for extraction is 20 to 85% by volume, more preferably 25 to 7% by volume. It is considered appropriate to perform at 0% by volume.
- Example 2 To examine the effect of pH during extraction, the same method as in Example 1 was used, and the pH of the aqueous polar organic solvent was changed as shown in Table 6, and the saponin recovery rate and isoflavone abundance ratio in the extract were measured. .
- the pH was adjusted using hydrochloric acid and sodium hydroxide solution.
- the pH of the water-containing polar organic solvent is preferably PH 4 to 9, which is near neutral, and more preferably pH 5 to 8.
- the present invention after the adsorbent treatment from the saponin-containing liquid extracted from the soybean raw material, it is possible to perform only one-step purification by the adsorbent treatment without performing multiple purification steps such as gel filtration and distribution mouth chromatography. It is also possible to industrially obtain a high-purity, high-yield saponin-containing material industrially, and to provide a method for producing a saponin-containing material with extremely high production efficiency. Therefore, it is extremely useful in industrial fields such as food, cosmetics, and pharmaceuticals.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Botany (AREA)
- Biochemistry (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Child & Adolescent Psychology (AREA)
- Toxicology (AREA)
- Steroid Compounds (AREA)
- Saccharide Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Description
Claims
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/507,637 US7638643B2 (en) | 2002-03-14 | 2003-03-11 | Process for producing soybean saponin-containing material |
JP2003574212A JP4428054B2 (ja) | 2002-03-14 | 2003-03-11 | 大豆サポニン含有物及びその製造法 |
AU2003211607A AU2003211607A1 (en) | 2002-03-14 | 2003-03-11 | Soybean saponin-containing material and process for producing the same |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2002070048 | 2002-03-14 | ||
JP2002-70048 | 2002-03-14 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2003075939A1 true WO2003075939A1 (fr) | 2003-09-18 |
Family
ID=27800330
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2003/002881 WO2003075939A1 (fr) | 2002-03-14 | 2003-03-11 | Substance contenant de la saponine de soja et procede de production associe |
Country Status (5)
Country | Link |
---|---|
US (1) | US7638643B2 (ja) |
JP (1) | JP4428054B2 (ja) |
CN (1) | CN100536863C (ja) |
AU (1) | AU2003211607A1 (ja) |
WO (1) | WO2003075939A1 (ja) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006094747A (ja) * | 2004-09-29 | 2006-04-13 | Ajinomoto Co Inc | 抗肥満作用を有する組成物及び飲食品 |
JP2006124324A (ja) * | 2004-10-28 | 2006-05-18 | J-Oil Mills Inc | 高純度大豆サポニンの製造方法 |
JP2011126835A (ja) * | 2009-12-19 | 2011-06-30 | Fuji Oil Co Ltd | サポニンの製造法 |
JP2011195541A (ja) * | 2010-03-23 | 2011-10-06 | Fuji Oil Co Ltd | グループbサポニンの製造法 |
WO2013001890A1 (ja) | 2011-06-28 | 2013-01-03 | 株式会社J-オイルミルズ | ソーヤサポゲノール組成物 |
JP2018538286A (ja) * | 2015-11-25 | 2018-12-27 | ナチュラル レスポンス、エセ.ア.Natural Response, S.A. | 植物からサポニンを得る方法 |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0723102D0 (en) * | 2007-11-26 | 2008-01-02 | Univ Brighton | Bioactive and resorbable soy-based biomaterials |
US8217165B2 (en) * | 2008-06-17 | 2012-07-10 | Pawan Kumar Goel | Process for the extraction of furostanolic saponins from fenugreek seeds |
US8597712B2 (en) * | 2009-09-28 | 2013-12-03 | Whitewave Services, Inc. | Soy beverage substantially free of isoflavones and method of production |
KR20110138001A (ko) * | 2010-06-18 | 2011-12-26 | (주)아모레퍼시픽 | 유색콩 추출물을 함유하는 조성물 |
CN102351924A (zh) * | 2011-09-05 | 2012-02-15 | 江南大学 | 一种茶皂素提取液的浓缩方法 |
PL3009010T3 (pl) | 2011-12-19 | 2020-10-19 | Purecircle Sdn Bhd | Sposoby oczyszczania glikozydów stewiolowych |
BR112015014876B1 (pt) | 2012-12-19 | 2020-11-03 | Purecircle Sdn Bhd | rebaudiosídeo x amorfo, composição edulcorante compreendendo o dito rebaudiosídeo x, método para preparar o rebaudiosídeo x amorfo e método para preparar uma bebida |
EP2986149B1 (en) | 2013-03-15 | 2019-08-21 | The Coca-Cola Company | Novel glucosyl steviol glycosides, their compositions and their purification |
CN105283464B (zh) | 2013-03-15 | 2018-02-13 | 可口可乐公司 | 甜菊醇糖苷、其组合物以及其纯化 |
EP3683315A1 (en) | 2014-08-19 | 2020-07-22 | Purecircle SDN BHD | Method for preparing rebaudioside m |
BR112017004240B1 (pt) | 2014-09-02 | 2022-04-05 | The Coca-Cola Company | Processo para preparar uma composição de glicosídeo de esteviol aquoso não tratado, extrato de stevia aquoso não tratado preparado pelo referido processo e alimento ou bebida |
EP3223609B1 (en) | 2014-11-29 | 2021-08-25 | The Coca-Cola Company | Novel diterpene glycosides, compositions and purification methods |
EP3340807A4 (en) | 2015-08-27 | 2019-05-08 | PureCircle SDN BHD | STEVIA EXTRACTS |
EP3766362B1 (en) | 2015-10-02 | 2022-12-28 | The Coca-Cola Company | Method of production of steviol glycoside sweeteners with improved flavor profiles |
WO2017172766A1 (en) | 2016-03-28 | 2017-10-05 | The Coca-Cola Company | Sweetness and taste improvement of steviol glycoside or mogroside sweeteners with flavonids |
AU2017246876B2 (en) | 2016-04-06 | 2021-09-23 | The Coca-Cola Company | Sweetness and taste improvement of steviol glycoside or mogroside sweeteners |
EP3547850B1 (en) | 2016-12-01 | 2024-05-15 | PureCircle USA Inc. | Stevia plant and uses thereof |
AU2019263007A1 (en) | 2018-04-30 | 2020-12-03 | The Coca-Cola Company | Methods for improving the solubility of steviol glycoside mixtures, and uses |
MX2022003500A (es) | 2019-09-27 | 2022-07-12 | Coca Cola Co | Mezclas de edulcorantes con sabor mejorado. |
CN110702843B (zh) * | 2019-09-30 | 2022-05-17 | 东莞微领生物科技有限公司 | 无患子皂苷标准品的非标定量测定试剂盒及测定方法 |
KR20240046918A (ko) | 2021-09-01 | 2024-04-11 | 더 코카콜라 컴파니 | 카페인 및/또는 이의 유도체 및 폴리페놀을 포함하는 조성물 및 방법 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6136225A (ja) * | 1984-07-30 | 1986-02-20 | Airin:Kk | サポニン類の単離法 |
JPH0436242A (ja) * | 1990-05-30 | 1992-02-06 | Fuji Oil Co Ltd | 大豆サポニンの製造法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS61129134A (ja) * | 1984-11-28 | 1986-06-17 | Airin:Kk | 大豆よりのサポニンの精製法 |
JPS625917A (ja) * | 1985-07-03 | 1987-01-12 | Airin:Kk | 大豆胚芽よりのイソフラボン類を含有しないサポニンの製造法 |
JPH08283283A (ja) * | 1995-04-14 | 1996-10-29 | Kikkoman Corp | マロニルイソフラボン配糖体及び該物質からイソフラボン配糖体又はイソフラボンアグリコンを取得する方法 |
US6033714A (en) * | 1996-03-13 | 2000-03-07 | Archer Daniels Midland Company | Process for production of isoflavone fractions from soy |
-
2003
- 2003-03-11 US US10/507,637 patent/US7638643B2/en not_active Expired - Fee Related
- 2003-03-11 JP JP2003574212A patent/JP4428054B2/ja not_active Expired - Fee Related
- 2003-03-11 AU AU2003211607A patent/AU2003211607A1/en not_active Abandoned
- 2003-03-11 CN CNB038100959A patent/CN100536863C/zh not_active Expired - Fee Related
- 2003-03-11 WO PCT/JP2003/002881 patent/WO2003075939A1/ja active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6136225A (ja) * | 1984-07-30 | 1986-02-20 | Airin:Kk | サポニン類の単離法 |
JPH0436242A (ja) * | 1990-05-30 | 1992-02-06 | Fuji Oil Co Ltd | 大豆サポニンの製造法 |
Non-Patent Citations (3)
Title |
---|
GRIFFITH AARON P. ET AL.: "Improved methods for the extraction and analysis of isoflavones from soy-containing food and nutritional supplements by reversed-phase high-performance liquid chromatography and liquid chromatography-mass spectrometry", J. CHROMATOGRAPHY A, vol. 913, 2001, pages 397 - 413, XP004232806 * |
MAKOTO SHIMOYAMADA ET AL.: "Partition of soybean saponins between butanol and water", FOOD SCI. TECHNOL. INT., vol. 1, no. 2, 1995, pages 112 - 114, XP002969475 * |
MAKOTO SHIMOYAMADA ET AL.: "Solubilities of soybean saponins and their solubilization with a bisdesmoside saponin", NIPPON SHOKUHN KOGYO GAKKAISHI, vol. 40, no. 3, 1993, pages 210 - 213, XP002969474 * |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006094747A (ja) * | 2004-09-29 | 2006-04-13 | Ajinomoto Co Inc | 抗肥満作用を有する組成物及び飲食品 |
JP2006124324A (ja) * | 2004-10-28 | 2006-05-18 | J-Oil Mills Inc | 高純度大豆サポニンの製造方法 |
JP4632024B2 (ja) * | 2004-10-28 | 2011-02-16 | 株式会社J−オイルミルズ | 高純度大豆サポニンの製造方法 |
JP2011126835A (ja) * | 2009-12-19 | 2011-06-30 | Fuji Oil Co Ltd | サポニンの製造法 |
JP2011195541A (ja) * | 2010-03-23 | 2011-10-06 | Fuji Oil Co Ltd | グループbサポニンの製造法 |
WO2013001890A1 (ja) | 2011-06-28 | 2013-01-03 | 株式会社J-オイルミルズ | ソーヤサポゲノール組成物 |
JP2018538286A (ja) * | 2015-11-25 | 2018-12-27 | ナチュラル レスポンス、エセ.ア.Natural Response, S.A. | 植物からサポニンを得る方法 |
JP7120921B2 (ja) | 2015-11-25 | 2022-08-17 | ナチュラル レスポンス、エセ.ア. | 植物からサポニンを得る方法 |
US11510954B2 (en) | 2015-11-25 | 2022-11-29 | Desert King Chile S.A. | Method for obtaining saponins from plants |
Also Published As
Publication number | Publication date |
---|---|
AU2003211607A1 (en) | 2003-09-22 |
CN100536863C (zh) | 2009-09-09 |
JPWO2003075939A1 (ja) | 2005-06-30 |
US20050123662A1 (en) | 2005-06-09 |
CN1649609A (zh) | 2005-08-03 |
JP4428054B2 (ja) | 2010-03-10 |
US7638643B2 (en) | 2009-12-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4428054B2 (ja) | 大豆サポニン含有物及びその製造法 | |
US5789581A (en) | Process for obtaining malonyl isoflavone glycosides and obtaining isoflavone glycosides or isoflavone aglycons from malonyl isoflavone glycosides | |
JP3078694B2 (ja) | ゲニステインの製造法 | |
JP4442422B2 (ja) | 高濃度かつ高溶解性のイソフラボン含有組成物及びその製造法 | |
JPH10298175A (ja) | 水易溶性大豆イソフラボンの製造方法 | |
US6479054B1 (en) | Process for obtaining genistin-rich isoflavone composition | |
KR100379642B1 (ko) | 대두 배아로부터 발효를 통한 고순도 이소플라본아글리콘의 생산방법 | |
US20090312293A1 (en) | process for the isolation of pharmacologically active principles of vegetable and animal origin | |
JP2000262244A (ja) | 大豆イソフラボン含有組成物とその製造方法 | |
JPH11263786A (ja) | イソフラボン化合物の製造法 | |
US7863466B2 (en) | Method of producing proanthocyanidin-containing material | |
WO2005097815A1 (ja) | グループbサポニンの製造方法 | |
JP4279982B2 (ja) | 風味の良好な高純度大豆イソフラボンおよびそれを用いた食品 | |
JP5487947B2 (ja) | サポニンの製造法 | |
JP2003171393A (ja) | 高純度大豆サポニンの製造方法 | |
JP2912133B2 (ja) | 新規イソフラボン誘導体およびその製造方法 | |
KR101898397B1 (ko) | 컬럼 추출 기술을 이용한 고함량의 대두 이소플라본 추출물 및 그 제조방법 | |
KR19990032601A (ko) | 아글루콘 이소플라본이 풍부한 식물성 단백질 유장, 유장 단백질 재료, 아글루콘 이소플라본 재료, 제니스테인 함량이 높은재료 및 다이드제인 함량이 높은 재료 및 식물성 단백질 유장으로부터 이들을 제조하는 방법 | |
Choi et al. | Extraction of isoflavones from soybean hypocotyl using aqueous ethanol | |
KR100347668B1 (ko) | 개선된 이소플라본 추출 방법 | |
JP2002003487A (ja) | イソフラボン化合物の製造方法 | |
JPH11155592A (ja) | アグリコンイソフラボン強化植物性タンパク質乳清、乳清タンパク質物質、アグリコンイソフラボン物質、高ゲニステイン含有物質、及び高ダイドゼイン含有物質、並びにこれらの植物性タンパク質乳清からの製造法 | |
JP2007223915A (ja) | ダイゼイン類に富むイソフラボン組成物の製造法 | |
JP2011195541A (ja) | グループbサポニンの製造法 | |
JPWO2003000674A1 (ja) | 可溶性イソフラボン含有組成物の製造方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2003574212 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10507637 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 20038100959 Country of ref document: CN |
|
122 | Ep: pct application non-entry in european phase |